← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 8, 2018Last known activity
Feb 26, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (31 distinct, 24 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (24)
- NCT06783257Lead sponsorPhase 2Feb 28, 2025
- NCT06863987Lead sponsorPhase 3Feb 5, 2025
- NCT06752447Lead sponsorPhase 1Jan 20, 2025
- NCT06722950Lead sponsorPhase 2Dec 31, 2024
- NCT06782594Lead sponsorPhase 2Oct 18, 2024
- NCT06755515Lead sponsorPhase 2/Phase 3Sep 26, 2024
- NCT06819774Lead sponsorPhase 3Apr 22, 2024
- NCT06226363Lead sponsorPhase 1Feb 1, 2024
- NCT06206915Lead sponsorPhase 1Feb 1, 2024
- NCT05741021Lead sponsorPhase 2Mar 1, 2023
- NCT05408221Lead sponsorPhase 2/Phase 3Aug 1, 2022
- NCT05305183Lead sponsorPhase 3May 31, 2022
- NCT05740215Lead sponsorPhase 1/Phase 2May 23, 2022
- NCT05293028Lead sponsorPhase 1May 20, 2022
- NCT05178836Lead sponsorPhase 2Jan 1, 2022
Details
- Last known activity
- Feb 26, 2026